Search

Your search keyword '"Forrest, Graeme N."' showing total 259 results
Start Over Author "Forrest, Graeme N."
259 results on '"Forrest, Graeme N."'

4. Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration

Author

Suda, Katie J, Livorsi, Daniel J, Goto, Michihiko, Forrest, Graeme N, Jones, Makoto M, Neuhauser, Melinda M, Hoff, Brian M, Ince, Dilek, Carrel, Margaret, Nair, Rajeshwari, Knobloch, Mary Jo, and Goetz, Matthew B

Subjects
Biomedical and Clinical Sciences, Health Sciences, Anti-Bacterial Agents, Antimicrobial Stewardship, Centers for Disease Control and Prevention, U.S., Decision Support Techniques, Drug Utilization, Guidelines as Topic, Humans, Interprofessional Relations, Research, United States, United States Department of Veterans Affairs, Medical and Health Sciences, Epidemiology, Biomedical and clinical sciences, Health sciences
Abstract

Antimicrobial stewardship is vital to reducing the spread of antimicrobial resistance. A group of investigators and clinicians within the Veterans Health Administration set forth a research agenda for antimicrobial stewardship, including research targets for inpatient and outpatient stewardship activities, metrics, and antimicrobial dosing and duration.

Published
2018

6. Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

Author

Kidd, Sarah E., primary, Hagen, Ferry, additional, Halliday, Catriona L., additional, Abdolrasouli, Alireza, additional, Boekhout, Teun, additional, Crous, Pedro W., additional, Ellis, David H., additional, Elvy, Juliet, additional, Forrest, Graeme N., additional, Groenewald, Marizeth, additional, Hahn, Rosane C., additional, Houbraken, Jos, additional, Rodrigues, Anderson M., additional, Scott, James, additional, Sorrell, Tania C., additional, Summerbell, Richard C., additional, Tsui, Clement K. M., additional, Yurkov, Andrey, additional, and Chen, Sharon C.-A., additional

Published
2024
Full Text
View/download PDF

7. Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

Author

Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, Chen, Sharon C.A., Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, and Chen, Sharon C.A.

Published
2024

8. Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

Author

MMB, MMB Medische Staf, Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, Chen, Sharon C.A., MMB, MMB Medische Staf, Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, and Chen, Sharon C.A.

Published
2024

9. Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

Author

Kidd, Sarah E, Hagen, Ferry, Halliday, Catriona L, Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W, Ellis, David H, Elvy, Juliet, Forrest, Graeme N, Groenewald, Marizeth, Hahn, Rosane C, Houbraken, Jos, Rodrigues, Anderson M, Scott, James, Sorrell, Tania C, Summerbell, Richard C, Tsui, Clement K M, Yurkov, Andrey, Chen, Sharon C-A, Kidd, Sarah E, Hagen, Ferry, Halliday, Catriona L, Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W, Ellis, David H, Elvy, Juliet, Forrest, Graeme N, Groenewald, Marizeth, Hahn, Rosane C, Houbraken, Jos, Rodrigues, Anderson M, Scott, James, Sorrell, Tania C, Summerbell, Richard C, Tsui, Clement K M, Yurkov, Andrey, and Chen, Sharon C-A

Published
2024

10. Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

Author

Sub Molecular Microbiology, Molecular Microbiology, Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, Chen, Sharon C.A., Sub Molecular Microbiology, Molecular Microbiology, Kidd, Sarah E., Hagen, Ferry, Halliday, Catriona L., Abdolrasouli, Alireza, Boekhout, Teun, Crous, Pedro W., Ellis, David H., Elvy, Juliet, Forrest, Graeme N., Groenewald, Marizeth, Hahn, Rosane C., Houbraken, Jos, Rodrigues, Anderson M., Scott, James, Sorrell, Tania C., Summerbell, Richard C., Tsui, Clement K.M., Yurkov, Andrey, and Chen, Sharon C.A.

Published
2024

16. Breakthrough SARS‐CoV‐2 infections among recipients of tixagevimab‐cilgavimab prophylaxis: A citywide real‐world effectiveness study.

Author

Lendacki, Frances R., Li, Linda, Forrest, Graeme N., Jordan, Leirah, Zelinski, Christy, Black, Stephanie R., Ison, Michael G., and Seo, Jennifer Y.

Subjects
BREAKTHROUGH infections, PANDEMIC preparedness, PREVENTIVE medicine, PRE-exposure prophylaxis, METROPOLIS
Abstract

There are limited real‐world data on the effectiveness of tixagevimab‐cilgavimab as pre‐exposure prophylaxis of COVID‐19. We describe lessons learned when coordinating data collection and identifying breakthrough SARS‐CoV‐2 infections among patients across indications and institutions in a major US city. The Chicago Department of Public Health requested patient‐level tixagevimab‐cilgavimab administration data from all prescribing providers in Chicago, for treatments December 8, 2021 through June 30, 2022. Records were matched to COVID‐19 vaccinations and laboratory‐confirmed SARS‐CoV‐2 infections through December 31, 2022. Due to difficulty collecting data from all providers, targeted follow‐up was conducted to improve completeness on key variables (demographics, vaccination status, clinical indication for prophylaxis). Over half of reported tixagevimab‐cilgavimab administrations were to patients residing outside Chicago. Five hundred forty‐four Chicago residents who received at least one dose of tixagevimab‐cilgavimab were included in this analysis. Most were age 50 years or older (72%), Black non‐Latinx (33%) or White non‐Latinx (29%), and fully vaccinated (80%). Seventy‐five patients (14%) had laboratory‐confirmed COVID‐19. Patients with and without breakthrough infections were demographically similar. Clinical indication was missing for >95% of cases, improved to 64% after follow‐up; the most frequently specified was hematologic malignancy (10%). Severe outcomes were uncommon: 16% had documented COVID‐19‐related hospitalizations, one death was identified. Tixagevimab‐cilgavimab recipients in Chicago had a lower rate of severe SARS‐CoV‐2 infection than reported among other untreated high‐risk patients, including during predominance of non‐neutralizing variants. Improving stakeholder collaboration is essential for generation of real‐world effectiveness data, informing pandemic preparedness and optimizing use of medical countermeasures. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Implementation of a Prevention Bundle to Decrease Rates of Staphylococcus aureus Surgical Site Infection at 11 Veterans Affairs Hospitals

Author

Suzuki, Hiroyuki, primary, Perencevich, Eli N., additional, Hockett Sherlock, Stacey, additional, Clore, Gosia S., additional, O’Shea, Amy M. J., additional, Forrest, Graeme N., additional, Pfeiffer, Christopher D., additional, Safdar, Nasia, additional, Crnich, Christopher, additional, Gupta, Kalpana, additional, Strymish, Judith, additional, Lira, Gio Baracco, additional, Bradley, Suzanne, additional, Cadena-Zuluaga, Jose, additional, Rubin, Michael, additional, Bittner, Marvin, additional, Morgan, Daniel, additional, DeVries, Aaron, additional, Miell, Kelly, additional, Alexander, Bruce, additional, and Schweizer, Marin L., additional

Published
2023
Full Text
View/download PDF

27. SHEA statement on antibiotic stewardship in hospitals during public health emergencies

Author

Barlam, Tamar F., primary, Al Mohajer, Mayar, additional, Al-Tawfiq, Jaffar A., additional, Auguste, Antonie J., additional, Cunha, Cheston B., additional, Forrest, Graeme N., additional, Gross, Alan E., additional, Lee, Rachael A., additional, Seo, Susan K., additional, Suh, Kathryn N., additional, Volk, Stacy, additional, and Schaffzin, Joshua K., additional

Published
2022
Full Text
View/download PDF

28. Strategies for the implementation of a nasal decolonization intervention to prevent surgical site infections within the Veterans Health Administration

Author

Hockett Sherlock, Stacey, primary, Goedken, Cassie Cunningham, additional, Balkenende, Erin C., additional, Dukes, Kimberly C., additional, Perencevich, Eli N., additional, Reisinger, Heather Schacht, additional, Forrest, Graeme N., additional, Pfeiffer, Christopher D., additional, West, Katelyn A., additional, and Schweizer, Marin, additional

Published
2022
Full Text
View/download PDF

33. Unrecognized Pretransplant and Donor-Derived Cryptococcal Disease in Organ Transplant Recipients

Author

Cryptococcal Collaborative Transplant Study Group, Sun, Hsin-Yun, Alexander, Barbara D., Lortholary, Olivier, Dromer, Francoise, Forrest, Graeme N., Lyon, G. Marshall, Somani, Jyoti, Gupta, Krishan L., del Busto, Ramon, Pruett, Timothy L., Sifri, Costi D., Limaye, Ajit P., John, George T., Klintmalm, Goran B., Pursell, Kenneth, Stosor, Valentina, Morris, Michele I., Dowdy, Lorraine A., Munoz, Patricia, Kalil, Andre C., Garcia-Diaz, Julia, Orloff, Susan L., House, Andrew A., Houston, Sally H., Wray, Dannah, Huprikar, Shirish, Johnson, Leonard B., Humar, Atul, Razonable, Raymund R., Fisher, Robert A., Husain, Shahid, Wagener, Marilyn M., and Singh, Nina

Published
2010

34. Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis

Author

Sun, Hsin-Yun, Alexander, Barbara D., Lortholary, Olivier, Dromer, Francoise, Forrest, Graeme N., Lyon, G. Marshall, Somani, Jyoti, Gupta, Krishan L., del Busto, Ramon, Pruett, Timothy L., Sifri, Costi D., Limaye, Ajit P., John, George T., Klintmalm, Goran B., Pursell, Kenneth, Stosor, Valentina, Morris, Michelle I., Dowdy, Lorraine A., Munoz, Patricia, Kalil, Andre C., Garcia-Diaz, Julia, Orloff, Susan, House, Andrew A., Houston, Sally, Wray, Dannah, Huprikar, Shirish, Johnson, Leonard B., Humar, Atul, Razonable, Raymund R., Husain, Shahid, and Singh, Nina

Published
2009

38. FISH

Author

Forrest, Graeme N., primary, Mohammadi, Jwan, additional, and Mohammadi, Shahrzad, additional

Published
2015
Full Text
View/download PDF

43. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

Author

Sun, Hsin-Yun, Alexander, Barbara D., Lortholary, Olivier, Dromer, Francoise, Forrest, Graeme N., Lyon, G. Marshall, Somani, Jyoti, Gupta, Krishan L., del Busto, Ramon, Pruett, Timothy L., Sifri, Costi D., Limaye, Ajit P., John, George T., Klintmalm, Goran B., Pursell, Kenneth, Stosor, Valentina, Morris, Michele I., Dowdy, Lorraine A., Munoz, Patricia, Kalil, Andre C., Garcia-Diaz, Julia, Orloff, Susan L., House, Andrew A., Houston, Sally H., Wray, Dannah, Huprikar, Shirish, Johnson, Leonard B., Humar, Atul, Razonable, Raymund R., Fisher, Robert A., Husain, Shahid, Wagener, Marilyn M., and Singh, Nina

Subjects
Transplantation of organs, tissues, etc. -- Complications and side effects, Cryptococcal infections -- Patient outcomes, Cryptococcal infections -- Research, Cryptococcal infections -- Risk factors, Cryptococcus -- Research, Cryptococcus -- Health aspects, Health, Health care industry
Published
2010

46. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

Author

Fowler, Vance G., Boucher, Helen W., Corey, Ralph, Abrutyn, Elias, Karchmer, Adolf W., Rupp, Mark E., Levine, Donald P., Chambers, Henry F., Tally, Francis P., Vigliani, Gloria A., Cabell, Christopher H., Link, Arthur Stanley, DeMeyer, Ignace, Filler, Scott G., Zervos, Marcus, Cook, Paul, Parsonnet, Jeffrey, Bernstein, Jack M., Price, Connie Savor, Forrest, Graeme N., and Fatkenheuer, Gerd

Subjects
Daptomycin (Medication) -- Dosage and administration, Bacteremia -- Drug therapy, Endocarditis -- Drug therapy
Abstract

The efficacy and safety of daptomycin as compared with standard therapy for Staphylococcus aureus bacteremia and endocarditis are assessed. The results have shown that daptomycin is not inferior to standard therapy for Staphylococcus aureus bacteremia and right-sided endocarditis.

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results